US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Women's Health Market Research Reports & Industry Analysis

Women’s health is a perspective of prevention and treatment that looks at health concerns unique to females. Even though slightly more than half of the US population is female, medical research historically has neglected the health needs of women, other than reproductive issues. Recently there have been major changes in government and private support of women’s health research -- in policies, regulations, and the organization of research efforts.
In a recent Institute of Medicine (IOM) report, the Washington DC-based institute found that women’s health research has contributed to significant progress over the past 20 years in lessening the burden of disease and reducing deaths from some conditions for women, while other conditions have seen only moderate change or even little or no change. Gaps remain, both in research areas and in the application of results to benefit women in general and across multiple population groups.

Viewing women’s health exclusively as a function of sex differences is too narrow, according to the IOM report. It frames women’s health and well-being as a function only of biological factors and how they differ in men and women, and ignores the role of gender, which is affected by broader social and community factors. The IOM finds that there has been inadequate attention paid to the social and environmental factors that, along with biologic risk factors, influence women’s health. Although progress has been made in identifying behavioral determinants of women’s health, such as smoking, diet, and physical activity, few studies have tested ways to modify these determinants in women or examined the effects of social and community factors in specific groups of women. To advance this area of research, the IOM recommends that the National Institutes of Health (NIH) support research on common determinants and risk factors that underlie multiple diseases.

Significant progress has been made in reducing mortality for women from breast cancer, cardiovascular disease and cervical cancer. This can be attributed in part to increased consumer demand and awareness, which has resulted in additional funding and research; improved diagnosis; screening and treatment; and, in the case of cervical cancer, a vaccine.

RSS Feeds

Women's Health Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast – Worldwide
9/9/2014 | published by: Renub Research
... in double digit Billion US$ for 2013. United States is the leading market for breast cancer screening globally. China is expected to maintain its 2nd position in the forecasting period due to hefty number of ...  |  read more...
USD 1,490
Human Papillomavirus Infections - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... information on the therapeutic development for Human Papillomavirus Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Uterine Cancer - Pipeline Review, H2 2014
9/10/2014 | published by: Global Markets Direct
... therapeutic development for Uterine Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Female Hypoactive Sexual Desire Disorder, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Herceptin (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023
9/30/2014 | published by: GlobalData
... Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company Profiles” is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the solar PV ...  |  read more...
USD 3,495
Perjeta (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023
9/30/2014 | published by: GlobalData
... Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company Profiles” is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the solar PV ...  |  read more...
USD 3,495
Tykerb (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023
9/30/2014 | published by: GlobalData
... manufacture of petroleum products. The company operates in several countries across the globe under a number of brand names, including ExxonMobil, Exxon, Esso and Mobil. The company’s operations are located primarily in the US, Canada, ...  |  read more...
USD 3,495
PharmaPoint: HER2-Positive Breast Cancer - Japan Drug Forecast and Market Analysis to 2023
9/30/2014 | published by: GlobalData
... in five countries: the US, Canada, Egypt, Australia, and the UK North Sea. Its operations consist primarily of upstream activities, along with some exposure to midstream operations. As of December 31, 2013, Apache possessed proved ...  |  read more...
USD 4,995
PharmaPoint: HER2-Positive Breast Cancer - China Drug Forecast and Market Analysis to 2023
9/30/2014 | published by: GlobalData
... report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER2-positive breast cancer market, with coverage of multiple settings of the disease including neoadjuvant, adjuvant, first-, second-, third-, and ...  |  read more...
USD 4,995
PharmaPoint: HER2-Positive Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023
9/30/2014 | published by: GlobalData
... report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER2-positive breast cancer market, with coverage of multiple settings of the disease including neoadjuvant, adjuvant, first-, second-, third-, and ...  |  read more...
USD 6,995
Hot Flashes Global Clinical Trials Review, H2, 2014
9/10/2014 | published by: GlobalData
... information and data relating to the clinical trials on Hot Flashes. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Analysis of the Chinese Breast Imaging Systems Market
9/17/2014 | published by: Frost & Sullivan
... market. Primary research included interviews with product managers for each modality or country managers from the major OEMs, major distributors, and the medical community—including end users such as physicians, radiologists, and key opinion leaders (KOLs) ...  |  read more...
USD 6,000
Endometriosis - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... Endometriosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Metastatic Ovarian Cancer - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... information on the therapeutic development for Metastatic Ovarian Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Polycystic Ovarian Syndrome - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... information on the therapeutic development for Polycystic Ovarian Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Post Menopausal Osteoporosis - Pipeline Review, H2 2014
9/22/2014 | published by: Global Markets Direct
... information on the therapeutic development for Post Menopausal Osteoporosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Kadcyla (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023
9/30/2014 | published by: GlobalData
... Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company Profiles” is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the solar PV ...  |  read more...
USD 3,495
Neratinib (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023
9/30/2014 | published by: GlobalData
... upstream assets are located mainly in Appalachian Basin and the Southwestern region. The Southwestern region comprises the Permian Basin of West Texas, the Texas Panhandle, the Anadarko Basin of western Oklahoma, the Nemaha Uplift of ...  |  read more...
USD 3,495
PharmaPoint: HER2-Positive Breast Cancer - US Drug Forecast and Market Analysis to 2023
9/30/2014 | published by: GlobalData
... This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER2-positive breast cancer market, with coverage of multiple settings of the disease including neoadjuvant, adjuvant, first-, second-, third-, ...  |  read more...
USD 4,995
EU5 Uterine Fibroid Embolization (UFE) Procedures Outlook to 2020
7/31/2014 | published by: GlobalData
... The report provides procedure volumes within market segments - UFE Procedures using Gelatin Sponge Sheets and UFE Procedures using Polyvinyl Alcohol (PVA) Vials and Tris Acryl Gelatin Microsphere (TAGM) Vials. The data in the report ...  |  read more...
USD 450
Sexual Dysfunction Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... partnering deals •Top sexual dysfunction deals by value •Deals listed by company A-Z, industry sector, stage of development, technology type The Sexual Dysfunction Partnering 2009-2014 provides understanding and access to the sexual dysfunction partnering deals ...  |  read more...
USD 995
Global Adhesion Barriers Market : 2014-2018
8/13/2014 | published by: TechNavio - Infiniti Research Ltd.
... Covidien plc, Ethicon Inc. and Sanofi SA. Other Prominent Vendors in the market are: CollaGuard, FizoMed, Magen Orthomed, Novozymes and SyntheMed. Commenting on the report, an analyst from TechNavio’s team said: “the Global Adhesion Barriers ...  |  read more...
USD 2,500
Female Sexual Dysfunction - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... information on the therapeutic development for Female Sexual Dysfunction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Vaginal Atrophy (Atrophic Vaginitis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
France Gynecological Devices Market Outlook to 2020
7/31/2014 | published by: GlobalData
... of US dollars, volume (in units) and average prices (in US dollars) within market segments - Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings)), Endometrial Ablation Devices (Thermal ...  |  read more...
USD 2,500
< prev 1    3  4  5  6  7  8  9  10